Tag: peripheral arterial disease
SCAI welcomes FDA decision to remove red flag for use of paclitaxel-coated devices in PAD
The president of the ...
Boston Scientific announces position on FDA update about use of paclitaxel-coated devices to treat PAD
Following yesterday's new...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohe...
VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions
A worldwide committee...
ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use
Rupert Bauersachs (Da...
New guideline: ASA no longer recommended to prevent first stroke, heart disease
A new Heart & Stroke ...
Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients
The National Institute fo...
Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent
The MAJESTIC trial set ou...
